Best practices for long-term monitoring and follow-up of alemtuzumab-treated MS patients in real-world clinical settings https://t.co/jIopL4wG0P
10,217 followers
12,682 followers
RT @GavinGiovannoni: Alemtuzumab seems to be hogging the limelight. Could it be because it is the most effective licensed DMT we have? Or t…
834 followers
RT @GavinGiovannoni: Alemtuzumab seems to be hogging the limelight. Could it be because it is the most effective licensed DMT we have? Or t…
4,265 followers
RT @GavinGiovannoni: Alemtuzumab seems to be hogging the limelight. Could it be because it is the most effective licensed DMT we have? Or t…